Aura Biosciences
Cambridge
About Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $456.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2025)
- Ticker: nasdaq:AURA
- Website: aurabiosciences.com
- Phone: 617-812-0078
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aura-biosciences-44975 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.